ResMed (FRA:RMEA) Pre-Tax Income

: €1,019 Mil (TTM As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

Pretax income is the income that a company earns before paying income taxes. ResMed's pretax income for the three months ended in Dec. 2023 was €238 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was €1,019 Mil. ResMed's pretax margin was 22.31%.

During the past 13 years, ResMed's highest Pretax Margin was 27.72%. The lowest was 19.91%. And the median was 25.38%.

ResMed Pre-Tax Income Historical Data

The historical data trend for ResMed's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ResMed Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Pre-Tax Income

459.18

650.98

733.44

908.62

1,016.84

ResMed Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Pre-Tax Income																258.36	270.28	255.49	255.04	237.92

Competitive Comparison

For the Medical Instruments & Supplies subindustry, ResMed's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ResMed Pre-Tax Income Distribution

For the Medical Devices & Instruments industry and Healthcare sector, ResMed's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where ResMed's Pre-Tax Income falls into.

ResMed Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

ResMed's Pretax Income for the fiscal year that ended in Jun. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	1063.293	+	-2.727	+	-43.731	+	0	+	0.00100000000009
	=	1,017

ResMed's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	311.158	+	-60.58	+	-12.659	+	0	+	-2.8421709430404E-14
	=	238

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €1,019 Mil.

ResMed (FRA:RMEA) Pre-Tax Income Explanation

ResMed's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	237.919	/	1066.289
	=	22.31%

During the past 13 years, ResMed's highest Pretax Margin was 27.72%. The lowest was 19.91%. And the median was 25.38%.

ResMed Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of ResMed's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

ResMed (FRA:RMEA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ResMed Inc (FRA:RMEA) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

RSMDF:USA RMD:USA RMD:Mexico R1MD34:Brazil RMD:Australia

Address

9001 Spectrum Center Boulevard, San Diego, CA, USA, 92123

Website

https://www.resmed.com

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

ResMed (FRA:RMEA) Headlines

No Headlines